HAVCR2 and cancer: We used a well-annotated cohort of PDAC patients, for whom we had long-term survival data, and analyzed the expression levels of TIM3, IDO, B7H4, LAG3, VISTA and PD-L1 in cancer cells by IHC to obtain an overview of IC expression in this neoplasia.